Psoriasis on elbow. Credit: © hriana / Fotolia
Improvement persists for more than a year. About 80% of patients with moderate to severe psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab, according to 3 large, long-term clinical trials led by NW Medicine. “This group of studies not only shows very high and consistent levels of safety and efficacy, but also that the great majority of the responses persist at least 60 weeks,” said Dr. Kenneth Gordon.
Affecting about 3% of the world’s population, psoriasis is an immune-mediated inflammatory disease that causes itchy, dry and red skin. It is also associated with an increased risk for depression, heart disease and diabetes, among other conditions...
Read More
Recent Comments